Odyssey Health (ODYY) Share-based Compensation Growth (3y) (2022 - 2025)
Odyssey Health (ODYY) Share-based Compensation Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 5.29% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 13.40% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 0.56% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -69.87% |
| Jan 31, 2025 | -58.66% |
| Oct 31, 2024 | -51.59% |
| Jul 31, 2024 | -46.31% |
| Apr 30, 2024 | -68.90% |
| Jan 31, 2024 | 82.34% |
| Oct 31, 2023 | -76.23% |
| Jul 31, 2023 | -18.91% |
| Apr 30, 2023 | -33.61% |
| Jan 31, 2023 | 53.66% |
| Oct 31, 2022 | 3.69% |
| Jul 31, 2022 | -43.07% |
| Jan 31, 2022 | 121.58% |